FindTrial
Sign In

CT chest

RADIATION5 trials

Sponsors

National Cancer Institute (NCI), Aswan University, Alexandria University, New Valley University

Conditions

Acute LeukemiaCOPDHematologic DiseasesHodgkin's LymphomaImmunocompromised ICU Patients With Respiratory Tract InfectionsMultiple MyelomaMyelodysplastic SyndromesNon-Hodgkin's Lymphoma

Phase 1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
CompletedNCT02356159
National Cancer Institute (NCI)Acute Leukemia, Hodgkin's Lymphoma, Multiple Myeloma +2
Start: 2015-09-24End: 2025-03-25Updated: 2025-09-30

Unknown Phase

The Role of Computed Tomography in the Phenotyping of COPD Patients
CompletedNCT05747235
Aswan UniversityCOPD
Start: 2022-04-01End: 2023-12-31Updated: 2024-02-02
Difference Strain Ratio Ultrasound Elastography Between Benign and Malignant Peripheral Lung Lesions
NCT05752227
Alexandria UniversityPeripheral Lung Lesions
Start: 2022-06-01End: 2023-03-31Target: 120Updated: 2023-03-02
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
CompletedNCT06350526
New Valley UniversityHematologic Diseases
Start: 2024-09-27End: 2025-11-21Updated: 2025-11-24
Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections
Not yet recruitingNCT06387667
New Valley UniversityImmunocompromised ICU Patients With Respiratory Tract Infections
Start: 2025-12-01End: 2027-06-01Target: 250Updated: 2025-08-14

Related Papers

Radiological characterization of pulmonary involvement in patients with hematological diseases: a single-center retrospective study
Egyptian Journal of Bronchology2025-12-15
Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies
Blood2025-11-03
Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT
Blood2025-05-071 citations
Preconditioning Single High-Dose Palifermin Alters the Posttransplant Inflammatory Cytokine Profile
Blood2023-11-02
A Phase 1 Single Dose Escalation Study of Palifermin Administered Pre-Transplant Conditioning in Subjects Undergoing Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation
Blood2020-11-052 citations